HUP9900309A3 - Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases - Google Patents

Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases

Info

Publication number
HUP9900309A3
HUP9900309A3 HU9900309A HUP9900309A HUP9900309A3 HU P9900309 A3 HUP9900309 A3 HU P9900309A3 HU 9900309 A HU9900309 A HU 9900309A HU P9900309 A HUP9900309 A HU P9900309A HU P9900309 A3 HUP9900309 A3 HU P9900309A3
Authority
HU
Hungary
Prior art keywords
ridogrel
treatment
pharmaceutical compositions
inflammatory bowel
bowel diseases
Prior art date
Application number
HU9900309A
Other languages
Hungarian (hu)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HUP9900309A2 publication Critical patent/HUP9900309A2/en
Publication of HUP9900309A3 publication Critical patent/HUP9900309A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HU9900309A 1995-03-28 1996-03-18 Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases HUP9900309A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (2)

Publication Number Publication Date
HUP9900309A2 HUP9900309A2 (en) 1999-05-28
HUP9900309A3 true HUP9900309A3 (en) 1999-11-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900309A HUP9900309A3 (en) 1995-03-28 1996-03-18 Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486D0 (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (en) * 2001-03-12 2003-12-17 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
HUE032999T2 (en) 2009-02-16 2017-11-28 Nogra Pharma Ltd Alkylamido compounds and uses thereof
CN109999017A (en) 2012-02-09 2019-07-12 诺格拉制药有限公司 The method for treating fibrosis
CA2870490A1 (en) 2012-04-18 2013-10-24 Nogra Pharma Limited Methods of treating lactose intolerance
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
MX2021009498A (en) 2019-02-08 2021-09-08 Nogra Pharma Ltd Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
HUP9900309A2 (en) 1999-05-28
AR002727A1 (en) 1998-04-29
IL117670A (en) 2000-02-29
AU5397496A (en) 1996-10-16
MX9707394A (en) 1997-11-29
ZA962461B (en) 1997-09-29
NO974486L (en) 1997-09-29
NO974486D0 (en) 1997-09-29
IL117670A0 (en) 1996-07-23
CA2215160A1 (en) 1996-10-03
EP0817631A2 (en) 1998-01-14
JPH10511097A (en) 1998-10-27
WO1996030016A2 (en) 1996-10-03
WO1996030016A3 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
HUP9900950A3 (en) Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease
EP0808324A4 (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
EP0759750A4 (en) Compositions for treatment of chronic inflammatory diseases
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
HUT61661A (en) Process for producing pharmaceutical compositions for treating inflammatory gastrointestinal diseases
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
GB2292079B (en) Coated prednisolone preparation for the treatment of inflamatory bowel disease
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU6590896A (en) Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods
HUP0001084A3 (en) Modified release oral pharmaceutical composition containing 5-asa for the treatment of bowel diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
HUP9801686A3 (en) Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
GB2300807B (en) Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
GB9510162D0 (en) Compositions for the treatment of skin conditions